Deferred Tax Assets, Gross of Kairos Pharma, LTD. from 31 Dec 2023 to 31 Dec 2024

Taxonomy & unit
us-gaap: USD
Description
Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.
Summary
Kairos Pharma, LTD. quarterly Deferred Tax Assets, Gross in USD history and change rate from 31 Dec 2023 to 31 Dec 2024.
  • Kairos Pharma, LTD. Deferred Tax Assets, Gross for the quarter ending 31 Dec 2024 was $448,000.
Source SEC data
View on sec.gov
Deferred Tax Assets, Gross, Quarterly (USD)

Kairos Pharma, LTD. Quarterly Deferred Tax Assets, Gross (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2024 $448,000 +$448,000 31 Dec 2024 10-K 15 Apr 2025 2024 FY
Q4 2023 $0 31 Dec 2023 10-K 15 Apr 2025 2024 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.